Who owns BRIACELL THERAPEUTICS ORD?
- Ticker: BCTX
- CUSIP Number: 107930208
Tip: Access positions for across all investors
Analyze quarterly positions in Briacell Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Briacell Therapeutics Ord stock
Who bought or sold BRIACELL THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FNY Investment Advisers | 100.00 | $0 | -50% | Jun 2025 |
|
| Advisor Group Holdings | 66.00 | $48.001800 | 0% | Sep 2025 |
|
| Morgan Stanley | 13.00 | $38.000300 | 100% | Jun 2025 |
|
Who sold out of Briacell Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sabby Management | Jun 2025 | 40k | $116k |
| UBS Group | Jun 2025 | 15k | $45k |
| Federation des caisses Desjardins du Quebec | Jun 2025 | 3.5k | $10k |
| Royal Bank of Canada | Jun 2025 | 1.1k | $3.2k |
| Group One Trading | Jun 2025 | 708.00 | $2.1k |
| National Bank Of Canada /fi/ | Jun 2025 | 645.00 | $1.4k |
| SBI Securities | Jun 2025 | 600.00 | $1.8k |
| TD Waterhouse Canada | Jun 2025 | 190.00 | $543.001000 |
| Raymond James Financial | Jun 2025 | 102.00 | $300.002400 |
| Hanson McClain Advisors | Jun 2025 | 70.00 | $206.003000 |
| HHM Wealth Advisors | Jun 2025 | 66.00 | $194.997000 |
| Wells Fargo & Company | Jun 2025 | 32.00 | $94.316800 |